US FDA Approves First Reformulated Rx Ranitidine, Five Years After Withdrawal

 
• By Malcolm Spicer
  
The FDA approved VKT Pharma's 150- and 300-mg tablets of histamine H2-blocker ranitidine tablets. (Shutterstock)

More from Manufacturing

More from United States